AstraZeneca

NASDAQ: AZN · Real-Time Price · USD
78.87
0.40 (0.51%)
At close: Aug 15, 2025, 9:57 AM

AstraZeneca Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
5.49B 5.84B 6.17B 6.33B
Short-Term Investments
37M 20M 239M 69M
Long-Term Investments
1.73B 1.78B 903M 1.17B
Other Long-Term Assets
1.28B 5.65B 1.15B 1.07B
Receivables
8.3B 8.41B 7.21B 6.03B
Inventory
5.29B 5.42B 4.7B 8.98B
Other Current Assets
4.97B 3.75B 3.11B 3.32B
Total Current Assets
25.83B 25.05B 22.59B 26.24B
Property-Plant & Equipment
11.65B 10.5B 9.45B 10.17B
Goodwill & Intangibles
58.2B 58.14B 59.13B 62.38B
Total Long-Term Assets
78.21B 76.06B 73.89B 79.12B
Total Assets
104.03B 101.12B 96.48B 105.36B
Account Payables
3.64B 3.27B 2.55B 2.82B
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
2.16B 5.13B 6.27B 2.66B
Other Current Liabilities
17.31B 6.13B 3.81B 4.52B
Total Current Liabilities
27.87B 30.54B 26.29B 22.59B
Long-Term Debt
26.51B 22.36B 23.91B 29.72B
Other Long-Term Liabilities
4.37B 8.15B 8.5B 13.01B
Total Long-Term Liabilities
35.3B 31.41B 33.13B 43.48B
Total Liabilities
63.16B 61.95B 59.42B 66.08B
Total Debt
30.11B 28.62B 29.23B 30.78B
Common Stock
388M 388M 387M 387M
Retained Earnings
3.16B 4.52B -574M 1.71B
Comprehensive Income
n/a n/a -1.63B 111M
Shareholders Equity
40.79B 39.14B 37.04B 39.27B
Total Investments
1.9B 1.68B 1.14B 1.24B